BCL2L1 and colorectal carcinoma: Consistently, TCGA data showed that the BCL2L1 mRNA levels were robustly increased in CRC tissues compared to healthy colon tissues, and positively correlated with short overall survival in CRC patients (Figures 5P and S4A).